Search research articles
Contact Us
Filters
Showing results (201-210 of 223) with videos related to
Page
of 23
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice
K Mattson, L Bosquee, G Dabouis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 1, 1991
Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences
R Arriagada, B Pellae-Cosset, J C Ladron de Guevara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome
J-P Spano, F Andre, L Morat, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2000
Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
K Fizazi, R Caliandro, P Soulié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2007
Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer
L Taillade, F Penault-Llorca, T Boulet, et al.
Seminars in Oncology
|
August 24, 1999
Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer
T Le Chevalier, J Bérille, J R Zalcberg, et al.
Journal of the National Cancer Institute
|
February 22, 2001
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study
J L Pujol, J P Daurès, A Rivière, et al.
La Nouvelle Presse Medicale
|
May 30, 1981
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]
J Rouesse, T Tursz, T Le Chevalier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study
U Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Journal of the National Cancer Institute
|
December 18, 1996
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients
T Tursz, A L Cesne, P Baldeyrou, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 223) with videos related to
Sort By:
Page
of 23
Lung Cancer (Amsterdam, Netherlands)
|
September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice
K Mattson, L Bosquee, G Dabouis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 1, 1991
Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences
R Arriagada, B Pellae-Cosset, J C Ladron de Guevara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome
J-P Spano, F Andre, L Morat, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2000
Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
K Fizazi, R Caliandro, P Soulié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2007
Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer
L Taillade, F Penault-Llorca, T Boulet, et al.
Seminars in Oncology
|
August 24, 1999
Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer
T Le Chevalier, J Bérille, J R Zalcberg, et al.
Journal of the National Cancer Institute
|
February 22, 2001
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study
J L Pujol, J P Daurès, A Rivière, et al.
La Nouvelle Presse Medicale
|
May 30, 1981
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]
J Rouesse, T Tursz, T Le Chevalier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study
U Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Journal of the National Cancer Institute
|
December 18, 1996
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients
T Tursz, A L Cesne, P Baldeyrou, et al.
Page
of 23